Jordan Ulrich

Jordan Ulrich has an extensive work experience in various roles and industries. Starting from 2006, Jordan worked as a Project Intern at Paul Hemmer Companies. In 2008, Jordan worked as a Project Intern at BE&K Building Group, where they administered shop drawings and coordinated review processes. From 2009 to 2013, Jordan continued working with BE&K Building Group as an Assistant Project Manager, managing interiors fit-out projects and leading strategic planning sessions. In 2013, Jordan joined KBR, Inc. as a Project Engineer, where they were responsible for driving site design and engineering queries to closure. Jordan then moved on to BE&K Building Group once again in 2015, this time as a Project Manager. They oversaw projects and ensured contract administration and quality control. In 2017, Jordan joined Novo Nordisk as a Senior Project Manager, and in this role, they managed projects until 2021. Currently, Jordan holds the position of Head of Drug Substance Manufacturing at FUJIFILM Diosynth Biotechnologies, where they started in 2021. Additionally, they also serve as the Head of Project Delivery since November 2022.

Jordan Ulrich received their Bachelor of Science degree in Civil & Environmental Engineering from the University of Cincinnati between 2004 and 2009. Subsequently, they pursued a Master of Business Administration degree with a concentration in Operations Management at Elon University's Martha and Spencer Love School of Business from 2010 to 2012. In addition, Jordan Ulrich obtained a certification in Project Management (PMP) from the Project Management Institute, although the exact month and year of completion are not specified.